These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1399499)

  • 1. Vitamin A loading--an indicator of post-prandial lipoprotein clearance in healthy and hypertriglyceridemic subjects.
    Rassin T; Liron M; Rubinstein A; Arad J; Weintraub M
    Isr J Med Sci; 1992 Oct; 28(10):706-10. PubMed ID: 1399499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disturbances in dietary fat metabolism and their role in the development of atherosclerosis.
    Weintraub M; Charach G; Grosskopf I
    Biomed Pharmacother; 1997; 51(8):311-3. PubMed ID: 9436521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chylomicron-retinyl palmitate clearance in type I hyperlipidemic families.
    Sprecher DL; Knauer SL; Black DM; Kaplan LA; Akeson AA; Dusing M; Lattier D; Stein EA; Rymaszewski M; Wiginton DA
    J Clin Invest; 1991 Sep; 88(3):985-94. PubMed ID: 1885783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Defective remnant clearance as a risk factor for coronary heart disease].
    Wieland E; Walli AK; Niedmann PD; Lohstöter C; Krämer A; Seidel D
    Klin Wochenschr; 1990; 68 Suppl 22():63-7. PubMed ID: 2087082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different patterns of postprandial lipoprotein metabolism in normal, type IIa, type III, and type IV hyperlipoproteinemic individuals. Effects of treatment with cholestyramine and gemfibrozil.
    Weintraub MS; Eisenberg S; Breslow JL
    J Clin Invest; 1987 Apr; 79(4):1110-9. PubMed ID: 3470306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delayed increase in high density lipoprotein-phospholipids after ingestion of a fat load in normolipidemic patients with coronary artery disease.
    Groener JE; Scheek LM; van Ramshorst E; Krauss XH; van Tol A
    Atherosclerosis; 1998 Apr; 137(2):311-9. PubMed ID: 9622274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chylomicron remnant clearance from the plasma is normal in familial hypercholesterolemic homozygotes with defined receptor defects.
    Rubinsztein DC; Cohen JC; Berger GM; van der Westhuyzen DR; Coetzee GA; Gevers W
    J Clin Invest; 1990 Oct; 86(4):1306-12. PubMed ID: 2212015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dietary fat clearance in normal subjects is regulated by genetic variation in apolipoprotein E.
    Weintraub MS; Eisenberg S; Breslow JL
    J Clin Invest; 1987 Dec; 80(6):1571-7. PubMed ID: 3479440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does pravastatin increase chylomicron remnant catabolism in postmenopausal women with type 2 diabetes mellitus?
    Ng TW; Watts GF; Stuckey BG; Ching HL; Chan DC; Uchida Y; Sakai N; Yamashita S; Martins IJ; Redgrave TG; Barrett PH
    Clin Endocrinol (Oxf); 2005 Dec; 63(6):650-6. PubMed ID: 16343099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of lipolysis on chylomicron clearance and HDL cholesterol levels.
    Patsch J
    Eur Heart J; 1998 Jul; 19 Suppl H():H2-6. PubMed ID: 9717057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thyroxine replacement therapy enhances clearance of chylomicron remnants in patients with hypothyroidism.
    Weintraub M; Grosskopf I; Trostanesky Y; Charach G; Rubinstein A; Stern N
    J Clin Endocrinol Metab; 1999 Jul; 84(7):2532-6. PubMed ID: 10404832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postprandial intestinal-derived chylomicron and chylomicron remnants in essential hypertensive patients before and after prolonged captopril therapy.
    Iaina A; Silverberg DS; Wollman Y; Judevics R; Baruch R; Levhar C; Peer G; Blum M; Grosskopf I; Weintraub MS
    Am J Hypertens; 1995 Jan; 8(1):34-9. PubMed ID: 7734094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolism of apolipoprotein B in large triglyceride-rich very low density lipoproteins of normal and hypertriglyceridemic subjects.
    Packard CJ; Munro A; Lorimer AR; Gotto AM; Shepherd J
    J Clin Invest; 1984 Dec; 74(6):2178-92. PubMed ID: 6511922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormal lipid composition of chylomicrons in broad-beta disease (type 3hyperlipoproteinemia).
    Hazzard WR; Porte D; Bierman EL
    J Clin Invest; 1970 Oct; 49(10):1853-8. PubMed ID: 5460288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of dietary cholesterol in the regulation of postprandial apolipoprotein B48 levels in diabetes.
    Taggart C; Gibney J; Owens D; Collins P; Johnson A; Tomkin GH
    Diabet Med; 1997 Dec; 14(12):1051-8. PubMed ID: 9455933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the postprandial lipid metabolism: use of a 3-point test.
    Guerci B; Paul JL; Hadjadj S; Durlach V; Vergès B; Attia N; Girard-Globa A; Drouin P
    Diabetes Metab; 2001 Sep; 27(4 Pt 1):449-57. PubMed ID: 11547218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-density lipoproteins generated during an oral fat load in mild hypertriglyceridemic and healthy subjects are smaller, denser, and have an increased low-density lipoprotein receptor binding affinity.
    Noto D; Rizzo M; Barbagallo CM; Cefalù AB; Verde AL; Fayer F; Notarbartolo A; Averna MR
    Metabolism; 2006 Oct; 55(10):1308-16. PubMed ID: 16979400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe defect in clearing postprandial chylomicron remnants in dialysis patients.
    Weintraub M; Burstein A; Rassin T; Liron M; Ringel Y; Cabili S; Blum M; Peer G; Iaina A
    Kidney Int; 1992 Nov; 42(5):1247-52. PubMed ID: 1453610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolism of chylomicrons in patients with congenital lipoatrophic diabetes: a study with emulsion models of chylomicrons.
    Wajchenberg BL; Amâncio RF; Santomauro AT; Maranhão RC
    Clin Endocrinol (Oxf); 2004 Sep; 61(3):347-52. PubMed ID: 15355451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metformin enhances clearance of chylomicrons and chylomicron remnants in nondiabetic mildly overweight glucose-intolerant subjects.
    Grosskopf I; Ringel Y; Charach G; Maharshak N; Mor R; Iaina A; Weintraub M
    Diabetes Care; 1997 Oct; 20(10):1598-602. PubMed ID: 9314642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.